To search for clinical trials and detailed information on products in development, visit our Prevention Research & Development Database
showing 1-10 of 765
PxWire is AVAC’s quarterly update covering the latest in the field of biomedical HIV prevention research and development, implementation and advocacy. Each issue includes updates, emerging issues and upcoming events. Also available as a PDF. From...
Tuesday, November 28 at 7:00 AM ET Moderator: Richard Muko, Regional Implementation Advocacy Manager, AVAC Panelists: Joan Chamungu, Tanzanian Network of Women Living with HIV, Lawrence Khonyongwa, Malawi Network of People of Living with...
The Pandemic Accord negotiations are ongoing, and should come to fruition next year. What do they mean for your work, your country, and the future of global health? On Tuesday, November 21, 8:00 to 9:30 AM EST / 2:00 to 3:30 PM CEST, advocates came...
Tuesday, November 28 Between the recent accelerated growth in global PrEP initiations, and the introduction of new PrEP products like cabotegravir and the dapivirine vaginal ring, the field of PrEP data has never been more exciting or more...
This timeline shows the potential time points when the next-generation of HIV prevention options might find their way into new programs.
From the Lab to Jab are a series of briefs to learn the latest in vaccine R&D for HIV, COVID-19, TB and other global public health threats.
This issue brief on local vaccine production covers the current state of local production, what is needed to facilitate it, and ideas for advocacy to harness its potential.
This issue brief on mRNA technology covers what it is, how it works, current knowledge gaps and ideas for advocacy to harness its potential.
This issue brief covers the web of issues that influence access to vaccines.
This issue brief on the vaccine research and development (R&D) process is one of a series of four briefs.
showing 1-10 of 765